Welcome to our dedicated page for Ashland news (Ticker: ASH), a resource for investors and traders seeking the latest updates and insights on Ashland stock.
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company serving markets such as architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. The ASH news feed on Stock Titan brings together company announcements, earnings releases and operational updates that reflect how this specialty materials business is performing and evolving across its segments.
Investors following ASH news can review detailed quarterly and annual earnings releases, where Ashland discusses sales, segment performance in Life Sciences, Personal Care, Specialty Additives and Intermediates, and the impact of portfolio optimization and manufacturing network initiatives. These releases often describe demand trends in pharmaceuticals, personal care, coatings and intermediates, along with commentary on pricing, volumes and regional dynamics.
News items also include capital allocation updates such as quarterly cash dividend declarations on Ashland common stock and information about share repurchase activity referenced in proxy materials. Governance and leadership developments, including appointments or changes in senior management and board composition, are reported through press releases and related Form 8-K filings.
Operational updates can cover topics such as production network changes or incidents at manufacturing facilities, with Ashland explaining expected effects on operations, costs and customer deliveries. The company also uses news releases to communicate scheduling details for earnings conference call webcasts and to provide access information for investors and analysts.
By monitoring the ASH news page, readers can track how Ashland’s additives and specialty ingredients business responds to market conditions, executes its Execute, Globalize, Innovate and Invest strategy, and advances ESG and sustainability priorities described in its proxy statement and public communications.
Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.335 per share on its common stock. This dividend is scheduled for payment on December 15, 2022, to shareholders on record as of December 1, 2022. As of October 31, 2022, Ashland has 54,147,528 outstanding shares. Ashland is a global leader in additives and specialty ingredients, serving diverse markets including automotive, food and beverage, and pharmaceuticals, while emphasizing a commitment to environmental, social, and governance (ESG) principles.
Ashland Inc. (NYSE: ASH) reported Q4 fiscal 2022 results with sales of $631 million, a 7% increase year-over-year. Net income rose to $57 million, reflecting growth from $43 million in Q4 2021. Adjusted EBITDA was $147 million, slightly down from $149 million amid foreign currency challenges. The company expects 2023 sales between $2.5 billion and $2.7 billion, with adjusted EBITDA projected at $600 million to $650 million.
Summary not available.
Ashland Inc. (NYSE: ASH) has received the Commitment to Life Award in the Human Rights category from Natura & Co for its Responsible Solvers™ program. This initiative promotes sustainable guar farming and aims to educate farmers in Rajasthan, India, utilizing STEM principles. Natura & Co emphasizes collaboration with suppliers to address environmental and social challenges. The Commitment to Life Awards evaluate suppliers' positive impact projects, showcasing Ashland's commitment to corporate social responsibility and its role in global sustainability efforts.
Ashland Inc. (NYSE: ASH) has achieved EcoVadis Gold, highlighting its commitment to environmental, social, and governance (ESG) practices. This recognition places Ashland in the top 5% of over 100,000 evaluated companies. The rating reflects the company's management systems across several non-financial areas, including labor, ethics, and sustainable procurement. This award follows the launch of Ashland's ESG Report and an enhanced ESG online presence, emphasizing transparency and the company's mission to foster a better world.
Ashland Inc. (NYSE: ASH) has announced that the FDA has accepted its Viatel™ bioresorbable mPEG-PDLLA pharmaceutical excipient into the Novel Excipient Review Pilot Program. This program allows for the review of novel excipients before their use in drug formulations, aiming to enhance public health. The excipient serves as a polymeric carrier for targeted drug delivery. Ashland's participation underscores its commitment to innovation in pharmaceutical ingredients, facilitating the development of complex drug molecules for improved therapeutic outcomes.
Ashland Inc. (NYSE: ASH) announced its plans to issue fourth-quarter earnings on November 7, 2022, at 5 p.m. ET, followed by a live webcast for analysts on November 8, 2022, at 9 a.m. ET. The webcast will feature remarks from CEO Guillermo Novo and CFO Kevin Willis. Participants can join via phone by registering through an online link. Supporting materials, including a slide presentation, will be available on the Investor Relations section of Ashland's website. The archived version of the webcast will be accessible for 12 months.
Ashland Inc. (NYSE: ASH) has made notable advancements in its environmental, social, and governance (ESG) initiatives, as highlighted in its recent ESG report. The report aligns with the Paris Climate Accord's aims, reflecting a commitment to science-based emissions reduction targets. Ashland is part of the UN Global Compact and focuses on sustainable sourcing and operations. The company has achieved significant certifications, like the RSPO Supply Chain certification and EcoVadis Silver Status. CEO Guillermo Novo emphasized that these efforts integrate sustainability into the core of the business strategy, reinforcing the company's transformation.
Ashland Inc. (NYSE: ASH) announced that effective October 1, 2022, it will implement a price increase of up to 15% across all its products due to rising costs from inflation, energy, raw materials, freight, and labor. This increase applies to various markets including life sciences, personal care, and specialty additives. Ashland's proactive approach aims to align its pricing strategy with the ongoing economic pressures affecting production costs.
Ashland has announced a major expansion of its Viatel™ bioresorbable polymer facility in Mullingar, Ireland, aimed at increasing manufacturing and lab space. This expansion will double the facility's size and workforce, enhancing Ashland's ability to meet customer demands for innovative polymer chemistry in chronic disease treatments. The project, which began in June 2022, is expected to be completed by 2024, highlighting Ashland's commitment to the growing market for long-acting injectables and custom polymer production.
FAQ
What is the current stock price of Ashland (ASH)?
What is the market cap of Ashland (ASH)?
